glp-1 cardiovascular outcomes trial results august 2025 SGLT2 Inhibitors and Receptor Agonists in Cardiovascular–Kidney–Metabolic Syndrome Comparative cardiovascular effectiveness of newer

Cell Microbiol

When GLP-1 medications are contraindicated GLP-1 receptor agonists are contraindicated if you have: A personal or family history of medullary thyroid cancer A genetic condition called Multiple Endocrine Neoplasia type 2 (MEN-2) This warning comes from animal studies where rodents developed C-cell tumors

(See Table 1 for consolidated figures.) Other companies: Sanofi (once-sharing Europe insulin production with Novo) has limited GLP-1 exposure (insulin analog and one weekly GLP-1) and has not announced major capex in this area

Hashimotos is the most common cause of hypothyroidism in the United States and tends to affect women more than men